Results 81 to 90 of about 15,339 (211)
Introduction. Expresssion of tardive dyskinesia as one of the side effects of antipsychotic drugs causes various problems in psychotic patients. It is the main cause of patient"s drug incompliance.Vitamine E with it"s antioxidants properties might be an ...
M KAR AHMADI, F RAJAY
doaj
Physical Function–Tardive Dyskinesia (PATD) on Critical Patients in Intensive Care Unit
Introduction: Critical patients are patients who potentially get reversible dysfunction in one or more life-threatening organs and require care in the Intensive Care Unit (ICU). Methods: The objective of this research is to analyse the physical function-
Heru Suwardianto +3 more
doaj +1 more source
Drug-induced tardive dyskinesia
Tardive dyskinesia (TD) is a type caused by the use of different medications. The pathogenesis of TD is associated with dopamine receptor blockade, gamma-aminobutyric acid depletion, cholinergic deficiency, oxidative stress, impaired synaptic plasticity,
T. M. Ostroumova +3 more
doaj +1 more source
Abstract Background Deep brain stimulation (DBS) targeted to the globus pallidus (GP) can effectively alleviate dystonia symptoms. However, identifying optimal therapeutic stimulation parameters is challenging due to the manual programming process and the paucity of acute effects of DBS on dystonia symptoms.
Kara A. Johnson +7 more
wiley +1 more source
CLOZAPINE USE IN CASE WITH TREATMENT RESİSTANT CATATONIC SCHIZOPHRENIA AND TARDIVE DYSKINESIA
Clozapine use in a case with treatment resistant catatonic schizophrenia and tardive dyskinesia is an alternative treatment with superior efficacy in a substantial proportion of typical antipsychotic treatment-resistant schizophrenic patients.
Turgut Kundakçı
doaj
ObjectiveFour types of antipsychotic-induced movement disorders: tardive dyskinesia (TD), parkinsonism, akathisia and tardive dystonia, subtypes of TD (orofacial and limb truncal dyskinesia), subtypes of parkinsonism (rest tremor, rigidity, and ...
P Roberto Bakker +5 more
doaj +1 more source
Tourette Syndrome Research Highlights from 2017 [version 1; referees: 3 approved] [PDF]
This is the fourth yearly article in the Tourette Syndrome Research Highlights series, summarizing research from 2017 relevant to Tourette syndrome and other tic disorders. The authors briefly summarize reports they consider most important or interesting.
Black, Kevin J +2 more
core +2 more sources
Abstract Background Valbenazine is used to treat dyskinesia and is generally associated with limited side effects; however, a few cases with the adverse effect of parkinsonism are reported in the literature. In this study, we report a case of valbenazine‐induced acute parkinsonism.
Yasuhito Nagai +2 more
wiley +1 more source
Bringing together experts in reflux diseases, including gastroenterologists, surgeons, endoscopists, laryngologists, pulmonologists, and research scientists, the inaugural Gatherings in Esophagology (GiE) was held May 30–31, 2025, in France as a new initiative of Organisation mondiale d'Etudes Spécialisées pour les maladies de l'Oesophage (OESO).
Jennifer Cable +38 more
wiley +1 more source
Tardive Dyskinesia Associated with Paliperidone Palmitate
-Dear Editor, Paliperidone is an atypical antipsychotic drug formed by one of the active metabolites of risperidone, 9-hydroxirisperione.1 The drug demonstrates its effects by antagonizing central dopamine type-2 (D2) and serotonin type-2 (5HT2A ...
Sevda Korkmaz, Burcu Gundoğan
doaj +1 more source

